AndroGel Antitrust Case On Hold Amid Settlement Talk

By Jared Foretek · September 19, 2024, 9:09 PM EDT

A Pennsylvania federal judge has agreed to pause a class action against Abbott and other drugmakers over allegedly sham patent cases, saying a settlement between the two sides may be in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

KING DRUG COMPANY OF FLORENCE, INC. et al v. ABBOTT LABORATORIES et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 07, 2019

Recent Articles By Jared

September 05, 2024
Judge Orders Jury Trial Over Arbitration Bid In TCPA Fight
August 30, 2024
Period Tracker App Users Seek Class Cert. In Data-Selling Suit
August 26, 2024
FTC Mulls Proposal To Alter Puerto Rican Pharmacy Deal
August 15, 2024
Medical Records Co. Appealing Blocked Anti-Bot CAPTCHAs
August 12, 2024
States Want Teva Generic Price Fixing Case Tried 1st
August 07, 2024
Advocates Tell 9th Circ. To Revive Invisalign Monopoly Suit
July 30, 2024
AIDS Org Sues Express Scripts For PBM Monopoly
July 29, 2024
Judge Blocks Medical Records Co.'s Anti-Bot Captchas
July 26, 2024
Data Co. Told To Turn Over Contracts In Kochava Case
July 22, 2024
FTC Tells 5th Circ. Anesthesia Co. Can't Stop Antitrust Case